Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Developing treatments for indolent non hodgkin lymphoma

Dr Andrew Davies and Dr Paul Fields
Developing treatments for indolent non hodgkin lymphoma ( Dr Andrew Davies and Dr Paul Fields )
29 Apr 2015

Latest trials and outcomes with new CLL treatments

Dr George Follows and Professor Peter Hillmen
Latest trials and outcomes with new CLL treatments ( Dr George Follows and Professor Peter Hillmen )
29 Apr 2015

Updated results on phase III CLL trial shows 90% response rate using ibrutinib

Dr Claire Dearden - Royal Marsden Hospital, London, UK
Updated results on phase III CLL trial shows 90% response rate using ibrutinib ( Dr Claire Dearden - Royal Marsden Hospital, London, UK )
29 Apr 2015

The evolution of CLL treatment

Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista
The evolution of CLL treatment ( Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista )
28 Apr 2015

Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some

Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
27 Apr 2015

US breast cancer cases expected to increase by as much as 50 percent by 2030

Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA
US breast cancer cases expected to increase by as much as 50 percent by 2030 ( Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA )
27 Apr 2015

Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
27 Apr 2015

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )
27 Apr 2015

Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomarker

Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA
Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomarker ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )
27 Apr 2015

Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial

Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial ( Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
27 Apr 2015

How to decide the treatment of CLL in 2015

Dr Marco Montillo and Dr Maria Gomes da Silva
How to decide the treatment of CLL in 2015 ( Dr Marco Montillo and Dr Maria Gomes da Silva )
24 Apr 2015

Incorporating models of paediatric palliative care into India

Joan Marston - International Children's Palliative Care Network, Assagay, South Africa
Incorporating models of paediatric palliative care into India ( Joan Marston - International Children's Palliative Care Network, Assagay, South Africa )
21 Apr 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation